Investor Relations

If you are a current shareholder and your contact information has changed or you are not getting our updates, please reach out to us at

Our Vision

At Glytec, we are revolutionizing the landscape of diabetes care.  We envision a world where every instance of patient care is supported by data and actionable insights. We see a future where healthcare decisions are informed, ensuring better, cost-effective care and outcomes for patients and those with diabetes globally.

Glytec’s Industry Leading SaaS Platform


Trusted by 350+ hospitals, empowers collaborative diabetes management and insulin dosing, improving patient outcomes, reducing readmissions, and streamlining workflows while delivering a 6-8x ROI. The first-ever FDA-cleared cloud-based insulin management software is EMR-integrated, easy to set up, and validated by 127 patents and over 100 publications.


The Glytec Glucommander® solution, with clinical decision support, workflow alerts, patient monitoring, at-risk patient identification, and AI-driven analytics, is supported by a mission-driven team dedicated to helping healthcare leaders, clinicians and patients promote health equity and improve diabetes outcomes from hospital to home. We are on a mission, join us.